Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-03-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0510019103PMID 16537417PMCID PMC1450239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.

  2005cited by this paper
• A Loss-of-Function Mutation in Natriuretic Peptide Receptor 2 (Npr2) Gene Is Responsible for Disproportionate Dwarfism in cn/cn Mouse*

  2005cited by this paper
• Autonomic nervous system and blood pressure regulation in RGS2-deficient mice.

  2005cited by this paper
• Dendroaspis Natriuretic Peptide Induces the Apoptosis of Cardiac Muscle Cells

  2005cited by this paper
• Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.

  2004cited by this paper
• Rat corin gene: molecular cloning and reduced expression in experimental heart failure.

  2004cited by this paper
• Efficiency of transgenic rat production is independent of transgene-construct and overnight embryo culture.

  2004cited by this paper
• Forced Homodimerization by Site-Directed Mutagenesis Alters Guanylyl Cyclase Activity of Natriuretic Peptide Receptor B

  2004cited by this paper
• Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy.

  2004cited by this paper
• Regulation of the Guanylyl Cyclase-B Receptor by Alternative Splicing*

  2003cited by this paper
• Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts*

  2003cited by this paper
• Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.

  2003cited by this paper
• Pressure‐independent enhancement of cardiac hypertrophy in atrial natriuretic peptide–deficient mice

  2003cited by this paper
• Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.

  2003cited by this paper
• Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.

  2002cited by this paper
• Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice

  2002cited by this paper
• Agonistic Induction of a Covalent Dimer in a Mutant of Natriuretic Peptide Receptor-A Documents a Juxtamembrane Interaction That Accompanies Receptor Activation*

  2001cited by this paper
• A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy

  2001cited by this paper
• Cardiac fibrosis in mice lacking brain natriuretic peptide.

  2000cited by this paper
• The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.

  1999cited by this paper
• Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism.

  1999cited by this paper
• Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats.

  1999cited by this paper
• Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity.

  1998cited by this paper
• Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts

  1998cited by this paper
• Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide.

  1998cited by this paper
• Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans.

  1998cited by this paper
• Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

  1997cited by this paper
• Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.

  1997cited by this paper
• Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds.

  1997cited by this paper
• Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide

  1995cited by this paper
• Dominant Negative Mutations of the Guanylyl Cyclase-A Receptor

  1995cited by this paper
• Modulation of the beta-adrenergic response of cardiomyocytes by specific lipoxygenase products involves their incorporation into phosphatidylinositol and activation of protein kinase C.

  1994cited by this paper
• Action of C-type natriuretic peptide in isolated canine arteries and veins.

  1993cited by this paper
• PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells.

  1993cited by this paper
• C-type natriuretic peptide: a selective cardiovascular peptide.

  1993cited by this paper
• Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.

  1993cited by this paper
• Ligand-independent oligomerization of natriuretic peptide receptors. Identification of heteromeric receptors and a dominant negative mutant.

  1992cited by this paper
• Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

  1992cited by this paper
• Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

  1992cited by this paper
• Cardiovascular and renal actions of C-type natriuretic peptide.

  1992cited by this paper
• Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.

  1990cited by this paper
• Isolation of Glomeruli from Mammalian Kidneys by Graded Sieving

  1972cited by this paper
• Isolation of glomeruli from mammalian kidneys by graded sieving.

  1972cited by this paper

• The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease

  2024cites this paper
• Proto-oncogene cSrc-mediated RBM10 phosphorylation arbitrates anti-hypertrophy gene program in the heart and controls cardiac hypertrophy.

  2024cites this paper
• C-type natriuretic peptide (CNP): The cardiovascular system and beyond.

  2024cites this paper
• Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure

  2024cites this paper
• Sacubitril/valsartan attenuates atrial conduction disturbance and electrophysiological heterogeneity with ameliorating fibrosis in mice

  2024cites this paper
• Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden.

  2024cites this paper
• Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics

  2023cites this paper
• Developmental roles of natriuretic peptides and their receptors.

  2023cites this paper
• Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart

  2022cites this paper
• CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System

  2022cites this paper
• Natriuretic peptides and Forkhead O transcription factors act in a cooperative manner to promote cardiomyocyte cell cycle re-entry in the postnatal mouse heart

  2021cites this paper
• The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.

  2021cites this paper
• Natriuretic peptide receptor B maintains heart rate and sinoatrial node function via cyclic GMP-mediated signaling.

  2021cites this paper
• Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

  2021cites this paper
• Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.

  2021cites this paper
• Multiplicity of Nitric Oxide and Natriuretic Peptide Signalling in Heart Failure.

  2020cites this paper
• The therapeutic effect of B‐type natriuretic peptides in acute decompensated heart failure

  2020cites this paper
• Modeling heart failure in animal models for novel drug discovery and development

  2019cites this paper
• C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature

  2019cites this paper
• Cardiovascular Pleiotropic Effects of Natriuretic Peptides

  2019cites this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019cites this paper
• Star-PAP controlled alternative polyadenylation coupled poly(A) tail length regulates protein expression in hypertrophic heart

  2019cites this paper
• C-type natriuretic peptide: the heart’s guardian angel

  2019cites this paper
• Translational science: Newly emerging science in biology and medicine — Lessons from translational research on the natriuretic peptide family and leptin —

  2019cites this paper
• C-type natriuretic peptide co-ordinates cardiac structure and function

  2019cites this paper
• Novel variants in natriuretic peptide receptor 2 in unrelated patients with acromesomelic dysplasia type Maroteaux.

  2019cites this paper
• Natriuretic peptides in human heart: Novel insight into their molecular forms, functions, and diagnostic use.

  2019cites this paper
• Regulation of the Natriuretic Peptide Receptor 2 (Npr2) by Phosphorylation of Juxtamembrane Serine and Threonine Residues Is Essential for Bifurcation of Sensory Axons

  2018cites this paper
• Role of C-type natriuretic peptide in cardiac structure and function

  2018cites this paper
• Immunolocalization of natriuretic peptides and their receptors in goat (Capra hircus) heart

  2018cites this paper
• Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.

  2018cites this paper
• Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death

  2018cites this paper
• A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction

  2018cites this paper
• Evolving Role of Natriuretic Peptides from Diagnostic Tool to Therapeutic Modality.

  2018cites this paper
• Title Rats deficient C-type natriuretic peptide suffer from impairedskeletal growth without early death

  2018cites this paper
• Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity

  2017cites this paper
• Molecular Genetics of Isolated Acromesomelic Dysplasia

  2017cites this paper
• Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice

  2017cites this paper
• Suppression of Npr1, not Npr2 gene function induces hypertrophic growth in H9c2 cells in vitro.

  2017cites this paper
• Microdomains in the Cardiovascular System

  2017cites this paper
• Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice

  2017cites this paper
• Cyclic GMP/Protein Kinase Localized Signaling and Disease Implications

  2017cites this paper
• Molecular Physiology of Membrane Guanylyl Cyclase Receptors.

  2016cites this paper
• Chronic Hypobaric Hypoxia Induces Right Ventricular Hypertrophy and Apoptosis in Rats: Therapeutic Potential of Nanocurcumin in Improving Adaptation

  2016cites this paper
• C‐type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells

  2016cites this paper
• Genetics of human isolated acromesomelic dysplasia.

  2016cites this paper
• Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease

  2016cites this paper
• Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during β-adrenergic receptor activation-induced hypertrophic growth in rats.

  2016cites this paper
• Brain-specific natriuretic peptide receptor-B deletion attenuates high-fat diet-induced visceral and hepatic lipid deposition in mice.

  2016cites this paper
• MOLECULAR PHYSIOLOGY OF MEMBRANE GUANYLYL CYCLASE RECEPTORS

  2016cites this paper
• Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?

  2016cites this paper
• A NOVEL MUTATION IN NPR2 GENE IN A PATIENT WITH ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE.

  2015cites this paper
• Homozygous Sequence Variants in the NPR2 Gene Underlying Acromesomelic Dysplasia Maroteaux Type (AMDM) in Consanguineous Families

  2015cites this paper
• C-type natriuretic peptide attenuates lipopolysaccharide-induced acute lung injury in mice.

  2015cites this paper
• Recombinant human brain natriuretic peptide ameliorates trauma-induced acute lung injury via inhibiting JAK/STAT signaling pathway in rats

  2015cites this paper
• Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events

  2015cites this paper
• B‐type natriuretic peptide and heart failure: what can we learn from clinical trials?

  2015cites this paper
• Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in Mice

  2015cites this paper
• BNP and Heart Failure: Preclinical and Clinical Trial Data

  2015cites this paper
• Natriuretic peptides in animal models of cardiovascular disease

  2014cites this paper
• Regulation of hippocampal synaptic plasticity thresholds and changes in exploratory and learning behavior in dominant negative NPR-B mutant rats

  2014influential citation
• Natriuretic peptides in cardiometabolic regulation and disease

  2014cites this paper
• Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development

  2014cites this paper
• The receptor guanylyl cyclase Npr2 regulates the bifurcation of cranial sensory axons

  2013cites this paper
• Identification of small molecule NPR-B antagonists by high throughput screening — potential use in heart failure

  2013cites this paper
• Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB.

  2013cites this paper
• C-type natriuretic peptide: a new cardiac mediator.

  2013cites this paper
• Local Actions of Natriuretic Peptides and Nitric Oxide in Cardiac Remodeling: Implications for Therapy

  2013cites this paper
• Vasoactive peptides and the pathogenesis of pulmonary hypertension: role and potential therapeutic application.

  2013cites this paper
• Natriuretic peptide receptors and heart failure: to B or not to B blocked?

  2013cites this paper
• Attenuation of MicroRNA‐22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy

  2012cites this paper
• New players and new interactions within the natriuretic peptide system : mechanisms and pathophysiological consequences

  2012cites this paper
• Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling

  2012cites this paper
• [Recent advances in natriuretic peptide family genes and cardiovascular diseases].

  2012influential citation
• Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux

  2012cites this paper
• Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.

  2012cites this paper
• C-Type Natriuretic Peptide (CNP) and Postnatal Linear Growth

  2012cites this paper
• Natriuretic peptide system: an overview of studies using genetically engineered animal models

  2011cites this paper
• C-Type Natriuretic Peptide and Cardiac Fibrosis

  2011cites this paper
• Regulation of C-type natriuretic peptide expression.

  2011cites this paper
• Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides

  2011cites this paper
• Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I

  2011cites this paper
• In vivo models of cardiac diseases: application to drug development and screening

  2010cites this paper
• Visinin-like protein 1 regulates natriuretic peptide receptor B in the heart.

  2010influential citation
• Arg13 of B-Type Natriuretic Peptide Reciprocally Modulates Binding to Guanylyl Cyclase but Not Clearance Receptors

  2010cites this paper
• Rat models of cardiovascular diseases.

  2010cites this paper
• NPR-C: a component of the natriuretic peptide family with implications in human diseases

  2010cites this paper
• C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target.

  2010cites this paper
• miR-9 and NFATc3 Regulate Myocardin in Cardiac Hypertrophy*

  2010cites this paper
• Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes

  2010cites this paper
• C-type natriuretic peptide as a new regulator of food intake and energy expenditure.

  2010cites this paper
• Investigation of the vasoprotective role of C-type natriuretic peptide

  2010cites this paper
• Iatrogenic, Transgenic, and Naturally Occurring Models of Cardiomyopathy and Heart Failure

  2009cites this paper
• New insights into the role of natriuretic peptides in the regulation of apoptosis in cardiovascular system.

  2009cites this paper
• Natriuretic peptides: physiologic and analytic considerations.

  2009cites this paper
• Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases

  2009cites this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cites this paper
• Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond.

  2009cites this paper
• Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

  2009influential citation
• Downregulation of natriuretic peptide receptor-A: evidence for clathrin- and dynamin-independent internalization.

  2009cites this paper